Teacher Retirement System of Texas grew its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 30.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,746 shares of the medical equipment provider’s stock after acquiring an additional 637 shares during the period. Teacher Retirement System of Texas’ holdings in Zimmer Biomet Holdings were worth $322,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Bronfman E.L. Rothschild L.P. grew its stake in Zimmer Biomet Holdings by 25.3% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock worth $106,000 after purchasing an additional 167 shares in the last quarter. Parkside Financial Bank & Trust grew its stake in Zimmer Biomet Holdings by 3.9% in the second quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock worth $112,000 after purchasing an additional 33 shares in the last quarter. BB&T Investment Services Inc. acquired a new position in Zimmer Biomet Holdings in the second quarter worth about $144,000. Sandy Spring Bank grew its stake in Zimmer Biomet Holdings by 5.4% in the second quarter. Sandy Spring Bank now owns 1,288 shares of the medical equipment provider’s stock worth $166,000 after purchasing an additional 66 shares in the last quarter. Finally, Grove Bank & Trust grew its stake in Zimmer Biomet Holdings by 346.1% in the second quarter. Grove Bank & Trust now owns 1,316 shares of the medical equipment provider’s stock worth $169,000 after purchasing an additional 1,021 shares in the last quarter. Institutional investors own 85.36% of the company’s stock.

Zimmer Biomet Holdings, Inc. (NYSE ZBH) traded down $0.70 on Friday, hitting $112.37. The stock had a trading volume of 69,220 shares, compared to its average volume of 1,359,135. The company has a market capitalization of $22,893.63, a PE ratio of 14.01, a PEG ratio of 1.76 and a beta of 1.17. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.78 and a current ratio of 1.47. Zimmer Biomet Holdings, Inc. has a 52 week low of $99.11 and a 52 week high of $133.49.

Zimmer Biomet Holdings (NYSE:ZBH) last released its quarterly earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.74 by ($0.02). The business had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.83 billion. Zimmer Biomet Holdings had a net margin of 8.36% and a return on equity of 16.29%. The business’s quarterly revenue was down .8% on a year-over-year basis. During the same period last year, the firm posted $1.79 EPS. equities analysts forecast that Zimmer Biomet Holdings, Inc. will post 8.03 earnings per share for the current fiscal year.

WARNING: This piece of content was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2017/11/24/zimmer-biomet-holdings-inc-zbh-stake-increased-by-teacher-retirement-system-of-texas.html.

A number of research firms recently commented on ZBH. Zacks Investment Research downgraded Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a research note on Monday. Deutsche Bank AG upgraded Zimmer Biomet Holdings from a “hold” rating to a “buy” rating and set a $128.00 price target for the company in a research note on Tuesday, November 14th. Edward Jones upgraded Zimmer Biomet Holdings from a “hold” rating to a “buy” rating in a research note on Thursday, November 9th. Royal Bank Of Canada cut their target price on shares of Zimmer Biomet Holdings to $125.00 and set an “outperform” rating on the stock in a report on Tuesday, November 7th. Finally, Stifel Nicolaus reissued a “hold” rating and issued a $120.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, November 3rd. Four analysts have rated the stock with a sell rating, seven have issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Hold” and an average target price of $133.71.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Stock Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related stocks with our FREE daily email newsletter.